Aspire Biopharma Holdings, Inc.
ASBPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $145.4K in total; no superinvestor holds it.
Other share classesASBP
Holders of 5% or more of ASBPW
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aspire Biopharma Holdings, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Aspire Biopharma Holdings, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Aspire Biopharma Holdings, Inc., newest first.
No Schedule 13D or 13G filings on Aspire Biopharma Holdings, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Aspire Biopharma Holdings, Inc. shares.
No Form 144 notices for Aspire Biopharma Holdings, Inc. are on file.